DE69529807T2 - Neue Parabansäure-Derivate als Aldose-Reduktase Inhibitoren - Google Patents

Neue Parabansäure-Derivate als Aldose-Reduktase Inhibitoren

Info

Publication number
DE69529807T2
DE69529807T2 DE69529807T DE69529807T DE69529807T2 DE 69529807 T2 DE69529807 T2 DE 69529807T2 DE 69529807 T DE69529807 T DE 69529807T DE 69529807 T DE69529807 T DE 69529807T DE 69529807 T2 DE69529807 T2 DE 69529807T2
Authority
DE
Germany
Prior art keywords
nitro
halogen
substituted
aldose reductase
new
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69529807T
Other languages
English (en)
Other versions
DE69529807D1 (de
Inventor
Takayuki Kotani
Kaoru Okamoto
Yasuhiro Nagaki
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nippon Zoki Pharmaceutical Co Ltd
Original Assignee
Nippon Zoki Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nippon Zoki Pharmaceutical Co Ltd filed Critical Nippon Zoki Pharmaceutical Co Ltd
Application granted granted Critical
Publication of DE69529807D1 publication Critical patent/DE69529807D1/de
Publication of DE69529807T2 publication Critical patent/DE69529807T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/96—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
DE69529807T 1994-12-20 1995-12-20 Neue Parabansäure-Derivate als Aldose-Reduktase Inhibitoren Expired - Fee Related DE69529807T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP33582094 1994-12-20

Publications (2)

Publication Number Publication Date
DE69529807D1 DE69529807D1 (de) 2003-04-10
DE69529807T2 true DE69529807T2 (de) 2003-11-20

Family

ID=18292778

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69529807T Expired - Fee Related DE69529807T2 (de) 1994-12-20 1995-12-20 Neue Parabansäure-Derivate als Aldose-Reduktase Inhibitoren

Country Status (5)

Country Link
US (1) US5681843A (de)
EP (1) EP0718289B1 (de)
AT (1) ATE233739T1 (de)
DE (1) DE69529807T2 (de)
ES (1) ES2193168T3 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6197806B1 (en) 1995-12-20 2001-03-06 Nippon Zoki Pharmaceutical Co., Ltd. Eliminating agent for activated oxygen and free radicals
JPH10182460A (ja) * 1996-12-27 1998-07-07 Nippon Zoki Pharmaceut Co Ltd ３−デオキシグルコソン生成阻害剤
AU754989B2 (en) 1998-11-16 2002-11-28 Nippon Zoki Pharmaceutical Co., Ltd. A therapeutic agent for intractable vasculitis
JP4711523B2 (ja) 2001-02-13 2011-06-29 日本臓器製薬株式会社 低アルブミン血症改善剤
TWI353979B (en) * 2002-04-10 2011-12-11 Nippon Zoki Pharmaceutical Co Novel crystal form of 5-hydroxy-1-methylhydantoin
US20060241162A1 (en) * 2005-04-20 2006-10-26 Kaoru Okamoto Optically active (R)-hydantoin derivative
US20060241163A1 (en) * 2005-04-20 2006-10-26 Kaoru Okamoto Optically active (S)-hydantoin derivative

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4099007A (en) * 1969-04-02 1978-07-04 Hoechst Aktiengesellschaft N,n-substituted 2,4,5-triketoimidazolidines and a process for their preparation
DE2612926A1 (de) * 1976-03-26 1977-10-06 Boehringer Mannheim Gmbh Neue acyl-derivate der 6-(alpha- amino-phenylacetamido)-penicillansaeure
AU578068B2 (en) * 1984-03-08 1988-10-13 Nippon Zoki Pharmaceutical Co., Ltd. Hydantoin derivatives and pharmaceutical compositions containing them
ATE50248T1 (de) * 1985-02-06 1990-02-15 Nippon Zoki Pharmaceutical Co Ein imidazolidintrion-derivat oder ein seiner pharmazeutisch akzeptierbaren salze enthaltende pharmazeutische zusammenstellung.
JPH01156965A (ja) * 1987-09-29 1989-06-20 Taiho Yakuhin Kogyo Kk チオヒダントイン化合物
JP2544183B2 (ja) * 1988-07-29 1996-10-16 日本臓器製薬株式会社 新規パラバン酸誘導体及び該化合物を有効成分として含有する医薬組成物
JPH02225485A (ja) * 1989-02-27 1990-09-07 Taiho Yakuhin Kogyo Kk チエノピリミジン―３―酢酸誘導体

Also Published As

Publication number Publication date
DE69529807D1 (de) 2003-04-10
US5681843A (en) 1997-10-28
EP0718289B1 (de) 2003-03-05
EP0718289A1 (de) 1996-06-26
ES2193168T3 (es) 2003-11-01
ATE233739T1 (de) 2003-03-15

Similar Documents

Publication Publication Date Title
FI904327A0 (fi) N-substituerad-4-pyrimidinaminer och -pyrimidindiaminer, foerfarande foer deras framstaellning och deras anvaendning som laekemedel.
EA200100755A1 (ru) 4-оксо-1,4-дигидро-3-хинолинкарбоксамиды как антивирусные агенты
AU4091389A (en) Antidepressant n-substituted nicotinamide compounds
DK0931788T3 (da) Metalloproteasehæmmere
DE69414019T2 (de) Bicyclische Stichstoff enthaltende Derivate als Prolyl-Endopeptidase Inhibitoren
DE69516186D1 (de) Verwendung von Beta-Aminopropionsäure-Derivaten als Fungizide
DE69529807T2 (de) Neue Parabansäure-Derivate als Aldose-Reduktase Inhibitoren
ATE230391T1 (de) Pyrrolidin derivate, anti-ulcus und antibakterielle arzneimittel
DE69526413D1 (de) Heterocyclische Carboxyalkylderivate
AU1890299A (en) Potassium channel activators
AU640590B2 (en) 3-(1h-indazol-3-yl)-4-pyridinamines
DK369289D0 (da) Anvendelse af imidazopyrazolderivater som analgetica og antiinflammatoriske midler
AU7589298A (en) 5-{(heteroaryl)alkyl}-3-oxo-pyrido{1,2-(a)}benzimidazole-4-c arboxamide derivatives useful in treating central nervous system disorders
DE69706012T2 (de) N-Acylpiperazinderivat, antibakterielle und gegen Geschwüre wirksame Medikamente

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee